Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MB

Markus Britschgi — 8 Patents

Hoffmann-La Roche: 5 patents #687 of 3,238Top 25%
UAUS Dept of Veterans Affairs: 3 patents #29 of 605Top 5%
Stanford University: 3 patents #905 of 5,197Top 20%
Allschwil, CH: #72 of 309 inventorsTop 25%
Overall (All Time): #600,572 of 4,157,543Top 15%
8 Patents All Time
Markus Britschgi has been granted 8 US patents while listed as an inventor at Hoffmann-La Roche. The first was granted in 2016 and the most recent in February 2024. Markus Britschgi ranks #600,572 of 4,157,543 US inventors in our database (top 14.4%). Patent records list Markus Britschgi in Allschwil, CH.

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11912998 Method of treating aging-associated cognitive impairment by reducing CCR3 Anton Wyss-Coray, Thomas A. Rando, Kaspar Rufibach, Saul A. Villeda 2024-02-27
11236340 Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3) Anton Wyss-Coray, Thomas A. Rando, Kaspar Rufibach, Saul A. Villeda 2022-02-01
10647761 Anti-alpha-synuclein antibodies and methods of use Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber 2020-05-12
10626399 Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) Anton Wyss-Coray, Thomas A. Rando, Kaspar Rufibach, Saul A. Villeda 2020-04-21
10316082 Anti-alpha-synuclein antibodies and methods of use Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber 2019-06-11
9890209 Anti-alpha-synuclein antibodies and methods of use Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber 2018-02-13
9670274 Anti-alpha-synuclein antibodies and methods of use Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber 2017-06-06
9493553 Anti-alpha-synuclein antibodies and methods of use Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber 2016-11-15